The P7 peptide antagonizes bFGF-induced malignant behaviors of ovarian cancer by inhibiting MEK/ERK signaling pathway
These findings suggest that P7 peptide suppresses bFGF-mediated OC progression by targeting the MEK/ERK pathway, supporting its potential as a novel therapeutic agent in OC.
Authors
- W. Wei (ORCID: https://orcid.org/0009-0003-1084-3271)
- Menglei Zhang (ORCID: https://orcid.org/0009-0007-0418-7377)
- Daolin Nie
- Qiong Chen
- Ziying Yang
Institutions
- Nanchang University (CN)
- Wenzhou Medical University (CN)
- Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University (CN)
- First Affiliated Hospital of Nanchang University (CN)
Publication Details
- Journal
- Future Science OA
- Published
- 2026-01-21
- DOI
- https://doi.org/10.1080/20565623.2026.2615619
- Primary Topic
- Protein Kinase Regulation and GTPase Signaling
- Type
- article
- Field-Weighted Citation Impact
- 0.00